Latest Medicine stories from Life.
As states increase scrutiny on corporate medicine, the telehealth sector faces significant challenges. The focus is on the corporate frameworks that support direct-to-consumer services.
The development of high-performance fiber lasers operating at the 2-micrometer wavelength presents new possibilities in fields such as medical technology and agriculture.
The ongoing Ebola outbreak in Congo's Ituri province has seen confirmed cases rise to 282, with over 1,000 suspected cases reported. The Bundibugyo virus poses significant challenges as there are no approved treatments or vaccines available.
Despite efforts to diversify medical schools, there remains a troubling gap in the representation of diverse doctors in residency programs. What is causing this disconnect?
Despite the Trump administration's reclassification of marijuana, it remains off-limits for truck drivers and pilots due to its lack of FDA approval and drug testing regulations.
The drug daraxonrasib has been found to significantly enhance survival rates for metastatic pancreatic tumors, coinciding with France's new prevention program launch.
In a continuing effort to combat drug trafficking, the U.S. military has carried out a fourth strike this week, resulting in three additional fatalities and raising the total death toll to 205.
Ivonescimab, a lung cancer treatment from China, garnered attention at ASCO for its potential to extend survival in patients with squamous cell lung cancer, though experts urge for trials involving a more diverse patient base.
A new study indicates that initiating hormone therapy before surgery may lead to lower relapse rates in prostate cancer patients, suggesting a shift in treatment strategies.
Recent findings presented at ASCO indicate significant progress in targeting a key component of pancreatic cancer, referred to as a 'greasy ball'.
Mark Goldsmith, CEO of Revolution Medicines, has announced the upcoming submission of daraxonrasib for FDA approval as the company begins shipping the experimental drug.
Former England footballer Raheem Sterling has been taken into custody on suspicion of drug driving, as reported by Sky News.
Replimune is set to make a third attempt for FDA approval of its drug, while Pfizer has recently secured a deal in China, highlighting ongoing developments in the pharmaceutical sector.
Questions remain about the implications of Trump's Most Favored Nation deals with pharmaceutical companies, as scrutiny increases.
Telehealth prescribers are now under heightened scrutiny following FDA warnings about compounded weight loss drugs, while Lilly is actively opposing certain compounding practices.
As the ASCO conference approaches, attention is drawn to pancreatic cancer developments, alongside significant biotech advancements including GSK's hepatitis B drug.
The FDA has postponed its decision on AstraZeneca's experimental breast cancer pill after an advisory panel voted against its approval, signaling further review is needed.
In response to a significant injury crisis, Tottenham Hotspur is reviewing their performance and medical departments, with a focus on the stadium's retractable pitch.
Following a three-hour medical visit at Walter Reed, former President Trump expressed satisfaction with his examination results, stating everything checked out perfectly.
Eli Lilly has announced encouraging results from a recent clinical trial of its gene-editing therapy, indicating a significant reduction in cholesterol levels among participants.